Fisher Asset Management LLC Decreases Holdings in Haleon plc (NYSE:HLN)

Fisher Asset Management LLC lowered its stake in Haleon plc (NYSE:HLN) by 2.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,737,776 shares of the company’s stock after selling 426,615 shares during the period. Fisher Asset Management LLC owned 0.32% of Haleon worth $121,292,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Hexagon Capital Partners LLC raised its holdings in shares of Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock worth $35,000 after buying an additional 2,193 shares during the last quarter. Pinnacle Bancorp Inc. increased its stake in shares of Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock worth $39,000 after acquiring an additional 4,267 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Haleon by 146.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock worth $44,000 after acquiring an additional 3,211 shares during the period. SRS Capital Advisors Inc. increased its stake in shares of Haleon by 456.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company’s stock worth $45,000 after acquiring an additional 4,477 shares during the period. Finally, Hoxton Planning & Management LLC acquired a new stake in shares of Haleon in the fourth quarter worth $85,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

Haleon stock opened at $8.39 on Monday. The firm has a 50 day simple moving average of $8.35 and a 200-day simple moving average of $8.33. Haleon plc has a 1-year low of $7.70 and a 1-year high of $8.96. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The stock has a market cap of $38.31 billion, a price-to-earnings ratio of 27.97, a price-to-earnings-growth ratio of 2.23 and a beta of 0.26.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The business had revenue of $3.70 billion during the quarter, compared to analysts’ expectations of $3.71 billion. On average, analysts expect that Haleon plc will post 0.46 EPS for the current year.

Wall Street Analysts Forecast Growth

HLN has been the topic of a number of research reports. Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. HSBC assumed coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a “buy” rating on the stock. Finally, Berenberg Bank assumed coverage on shares of Haleon in a research report on Wednesday, June 5th. They set a “buy” rating on the stock. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.